Concepedia

The anti-atherosclerotic effects of puerarin on induced-atherosclerosis in rabbits

Lidao Bao, Ying Zhang, Guomin Wei, Yi Wang, Ruilian Ma, Rui Cheng, Xianhua Ren, B. Agula

Biomedical Papers · 2014 · 40 citations · 16 references

DOIFull text

Open access

Abstract

Puerarin inhibits the formation and development of AS plaque and suppresses the migration and reproduction of vascular smooth muscle cells by decreasing PCNA and PDGF-A expressions in the rabbit. This is encouraging in terms of cardiovascular disease prevention/treatment.

References

16

Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

John C. LaRosa, Scott M. Grundy, David D. Waters et al. · New England Journal of Medicine · 2005 · 3.5K citations · Full text

Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration

Cheng-Feng Luo, Mu Yuan, Minsheng Chen et al. · International Journal of Pharmaceutics · 2011 · 156 citations

, , +7

Atheroprone Hemodynamics Regulate Fibronectin Deposition to Create Positive Feedback That Sustains Endothelial Inflammation

Ryan E. Feaver, Bradley D. Gelfand, Chong Wang et al. · Circulation Research · 2010 · 133 citations

Effect of substrate stiffness and PDGF on the behavior of vascular smooth muscle cells: Implications for atherosclerosis

Xin Q. Brown, Erzsébet Bartolák‐Suki, Corin Williams et al. · Journal of Cellular Physiology · 2010 · 96 citations · Full text

, , +19

Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin

The Journal of Nutritional Biochemistry · 2005 · 79 citations

, , +11